Composite autonomic symptom scale-31 (COMPASS-31) is useful for evaluation of autonomic dysfunction in patients with parkinsonism
Objective: To investigate the usefulness of composite autonomic symptom scale 31 (COMPASS-31) in patients with parkinsonism by comparing COMPASS-31 between PD and MSA patients, and…The clinical characteristics of Lewy body disease showed autonomic failures preceding motor signs
Objective: There are few cases of Lewy body disease who have been initially diagnosed as pure autonomic failure(PAF), because they had only autonomic symptoms for…Non-motor symptoms in a PPMI cohort of p.A53T α-synuclein mutation-related and sporadic Parkinson’s disease patients
Objective: To evaluate the prevalence of non-motor symptoms in p.A53T α-synuclein (SNCA) related Parkinson's disease (PD) as compared to sporadic Parkinson's disease (sPD) patients. Background:…Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)
Objective: The aim of this study was to evaluate the validity and reliability of the Turkish version of the SCOPA-AUT. Background: The scales for outcomes…Systematic literature review of droxidopa in clinical trials for neurogenic orthostatic hypotension (nOH) in parkinsonism
Objective: The aim of this study was to review the published evidence for the efficacy, safety, and dosing practices of droxidopa treatment for symptomatic neurogenic…Loss of heart rate variability in ALS: Time and frequency domain assessment
Objective: The aim of this study was to investigate alterations in cardiac autonomic control during sleep in patients affected by ALS. Background: Amyotrophic lateral sclerosis…Irritable bowel syndrome is more prevalent than functional constipation in Parkinson’s disease: Clinical spectrum and changes in gut microbiota
Objective: To assess distal functional gastrointestinal (GI) symptoms and their connection to fecal microbiota (FM) in Parkinson (PD) patients. Background: The majority of PD patients…Use of nicotine gum to treat acute low blood pressure in Parkinson’s disease
Objective: To evaluate (1) how nicotine chewing gum is tolerated (2) how nicotine chewing gum affects acute low blood pressure (BP) in Parkinson's disease (PD).…Application of Parkinson’s well-being map to assess impairment of digestive system in patients of Tomsk region, Russia
Objective: The aim of this study was to evaluate results of using Parkinson's Well-Being Map (WBM) in assessment of digestive and gut dysfunction in patients…Effects of pyridostigmine bromide vs. fludrocortison in the treatment of orthostatic hypotension in Parkinson’s disease
Objective: To report results of an investigator-initiated trial to show the non-inferiority of pyridostigmine bromide (PB) vs. fludrocortisone (FC) in the treatment of symptomatic orthostatic…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.